Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-458.6%EBIT Margin
VS
Market
Sector
Industry
History
$ 0.15Close
$ 0.15 - $ 1.11 52-Week Range
Ticker Information
Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQCARISMA THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
CARM - EBIT % Historical data
| Date | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ -49.38M | -458.6% | $ 10.77M |
| 3/31/2025 | $ -51.27M | -256.83% | $ 19.96M |
| 12/31/2024 | $ -60.48M | -308.05% | $ 19.63M |
| 9/30/2024 | $ -66.33M | -327.27% | $ 20.27M |
| 6/30/2024 | $ -75.97M | -366.85% | $ 20.71M |
| 3/31/2024 | $ -85.27M | -565.71% | $ 15.07M |
| 12/31/2023 | $ -88.81M | -595.31% | $ 14.92M |
| 9/30/2023 | $ -73.94M | -695.57% | $ 10.63M |
| 6/30/2023 | $ -31.15M | -66.56% | $ 46.8M |
| 3/31/2023 | $ -46.02M | -106.43% | $ 43.24M |
Key Performance Insights, Last 5 Years
- CARISMA THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -354.3%.
- Over the past 5 years, CARISMA THERAPEUTICS INC's average EBIT % has been -295.87%.
- The median EBIT % for CARISMA THERAPEUTICS INC during this period was -317.66%
- CARISMA THERAPEUTICS INC reached its highest EBIT % over the past 5 years at 205.79%.
- The lowest EBIT % recorded by CARISMA THERAPEUTICS INC in the same timeframe -757.37%
CARISMA THERAPEUTICS INC's EBIT % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT % Benchmarks
Similar metrics to Revenues:
- EBITDA Margin - [Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
- Operating Margin - [Calculation] A company’s operating income [OpInc] as a percentage of [Revenue]. The operating margin measures how much profit a company produces for each dollar of revenue generated, after paying for variable costs such as wages and raw materials.
Definition of EBIT Margin
[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.EBIT / Revenues
(=) EBIT % EBIT % for CARISMA THERAPEUTICS INC is calculated as follows: EBIT [ $ -39.81M ] / Revenues [ $ 11.24M ]
(=) EBIT % [ -354.3% ] CARM - EBIT Margin, Last 5 years
-757.37%
Minimum
Mar 31, 2021
205.79%
Maximum
Mar 31, 2022
-295.87%
Average
-317.66%
Median
EBIT % Benchmark AnalysisMarket
The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.56% with a standard deviation of 23.95%.
The following table provides additional summary stats:
EBIT % in the Market:
| filtered constituents | 3.26K |
|---|---|
| min | -73.16% |
| max | 83.08% |
| average | 9.56% |
| median | 9.02% |
| std | 23.95% |